Taysha Gene Therapies is a clinical-stage biotechnology company (Dallas, TX with a laboratory in Morrisville, NC) developing AAV-based gene therapies for rare monogenic diseases of the central nervous system. Its lead program, TSHA-102, targets Rett syndrome and has completed dosing in the REVEAL pivotal trial. The company operates as a therapeutics developer and publishes no public developer API, documentation portal, or technical integration surface; it was surfaced as a GV portfolio company and added to the API Evangelist network as an enrichment lead.
Taysha Gene Therapies * is profiled on the APIs.io network. Tagged areas include Company, Life Sciences, Biotechnology, Gene Therapy, and Rare Disease.
Regulatory Posture applies to this provider. Its tags matched the
Health regime, so
Regulatory Posture carries 15 points of the composite.
If this regime is wrong for your business, say so on your
provider repo — the
applicability map is public and we will correct it.
Create-or-Update Ergonomics could not be measured. We hold no machine-readable contract for
this provider to read, so there is nothing to measure a write surface against. Excluded rather than scored zero:
never-measured and measured-empty are different facts. Publishing an OpenAPI is what makes this facet — and
several others — scorable at all.
The six quality facets above are damped to 85 points between them,
because the conditional facet above carries the other
15. That is why each facet's contribution is shown against a damped
maximum: raising a quality facet moves the composite by 85% of its nominal
weight, not 100%. The full arithmetic is at apis.io/rating/.
aid: taysha-gene-therapies
deliveryModel:
model: unknown
open_source: false
commercial: false
callable_host: false
label: Delivery model not determined — needs a product licence on record
confidence: low
source:
- none
generated: '2026-08-28'
method: derived
accessModel:
pricing: unknown
onboarding: unknown
trial: false
try_now: false
public: false
label: Unknown
confidence: low
source: []
generated: '2026-07-22'
method: derived
image: https://kinlane-images.s3.amazonaws.com/shared/apis-json/icons/taysha-gene-therapies.png
name: Taysha Gene Therapies *
description: Taysha Gene Therapies is a clinical-stage biotechnology company (Dallas, TX with a laboratory in Morrisville,
NC) developing AAV-based gene therapies for rare monogenic diseases of the central nervous system. Its lead program, TSHA-102,
targets Rett syndrome and has completed dosing in the REVEAL pivotal trial. The company operates as a therapeutics developer
and publishes no public developer API, documentation portal, or technical integration surface; it was surfaced as a GV portfolio
company and added to the API Evangelist network as an enrichment lead.
url: https://raw.githubusercontent.com/api-evangelist/taysha-gene-therapies/refs/heads/main/apis.yml
x-type: company
x-source: vc-portfolio
x-backed-by:
- gv
x-tier: stub
x-tier-reason: portfolio-lead
specificationVersion: '0.23'
created: '2026-07-17'
modified: '2026-07-21'
tags:
- Company
- Life Sciences
- Biotechnology
- Gene Therapy
- Rare Disease
- Central Nervous System
- Clinical Stage
- Pharmaceuticals
apis: []
maintainers:
- FN: Kin Lane
email: kin@apievangelist.com
- FN: APIs.json
email: info@apis.io
common:
- type: DomainSecurity
url: security/taysha-gene-therapies-domain-security.yml
- type: Website
url: https://tayshagtx.com
x-enrichment:
date: '2026-07-21'
status: minimal
artifacts_added: 1
pass: local-v1
Discovery needs no key. Ratings and market analysis are Pro.
Get an API key
Free tier, no form to fill in. Signing in shares your email address with us — we
store it to create your key and to recognise you if you sign in with another
provider. See our Privacy Policy and
Terms.
Kin Score
How this is scored →